COVID-19 Saliva Screening Test Potential Global Market Report 2025

Description

The potential of saliva-based COVID-19 screening tests pertains to the possible benefits and capabilities they offer in comparison to conventional methods such as nasopharyngeal or oropharyngeal swab tests for detecting the SARS-CoV-2 virus, which causes COVID-19. This potential encompasses enhancements in testing accessibility, patient acceptance, cost-effectiveness, and safety, while also facilitating the adoption of new testing strategies and approaches for better management of the pandemic.

Key locations where the potential of COVID-19 saliva screening tests is prominent include travel stations, sports arenas, entertainment venues, corporate campuses, universities and colleges, factories, and similar settings. Travel stations are specifically designated areas within transportation hubs where individuals can undergo COVID-19 saliva screening tests before commencing their journeys. These tests utilize various technologies such as fluorescence-labeled antigen, rt-PCR, and CRISPR-Cas9, with testing conducted through centralized or decentralized approaches.

The COVID-19 saliva screening test potential market research report is one of a series of new reports from The Business Research Company that provides COVID-19 saliva screening test potential market statistics, including COVID-19 saliva screening test potential industry global market size, regional shares, competitors with a COVID-19 saliva screening test potential market share, detailed COVID-19 saliva screening test potential market segments, market trends, and opportunities, and any further data you may need to thrive in the COVID-19 saliva screening test potential industry. This COVID-19 saliva screening test potential market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The COVID-19 saliva screening test potential market size has grown strongly in recent years. It will grow from $3.9 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the potential for home testing, unprecedented need for diagnostic testing, rise in public awareness, and research and development investment.

The COVID-19 saliva screening test potential market size is expected to see strong growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration with screening programs, regulatory support, growing demand for speedy, point-of-care COVID-19 tests, increasing population, and the rise of e-commerce. Major trends in the forecast period include increasing adoption in non-healthcare settings, integration with digital health platforms, emergence of next-generation technologies, technological advancements, and strategic partnerships.

The growing healthcare expenditure is expected to drive the expansion of the COVID-19 saliva screening test market in the coming years. Healthcare expenditure includes all spending on healthcare-related products and services, such as prescription medications, hospital stays, doctor visits, medical equipment, and public health initiatives. The rise in healthcare expenditure is driven by factors like minimally invasive surgeries, advanced diagnostic technologies, increased research and development for new drugs, greater utilization of healthcare services, and the use of specialty medications. Higher healthcare spending provides the resources needed to fully leverage the potential of COVID-19 saliva screening tests, leading to more effective pandemic management and improved public health outcomes. For example, in 2022, according to the Office for National Statistics, the UK's healthcare expenditure reached around $354.88 billion (£283 billion), marking a slight increase of 0.7% compared to 2021. Therefore, the increase in healthcare expenditure is fueling the growth of the COVID-19 saliva screening test market.

Key players in the COVID-19 saliva screening test market are focusing on developing innovative technologies, such as data-sharing platforms, to improve real-time communication and collaboration among healthcare providers, laboratories, and public health authorities. This helps enhance the efficiency and accuracy of testing, tracking, and response efforts during the pandemic. Data-sharing platforms are digital systems that enable secure data exchange between various stakeholders, including healthcare providers, researchers, and organizations. They promote collaboration and facilitate access to information, thereby improving decision-making, efficiency, and outcomes across sectors. For example, in May 2024, Mount Sinai Health System, a US-based healthcare network, launched the Center for Healthcare Readiness. The Center is focused on enhancing strategies for public health emergency response, ensuring that healthcare systems can effectively manage large-scale crises, such as pandemics or natural disasters. It aims to strengthen the capacity of the Mount Sinai Health System and work with local, regional, and federal partners to develop comprehensive preparedness plans.

In July 2024, Hologic, Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. Through this acquisition, Hologic, Inc. aims to broaden its portfolio of innovative healthcare solutions and expand its presence in the women's health market. Endomagnetics Ltd. is a UK-based medical technology company that develops devices designed to detect cancerous lymph nodes during surgery.

Major companies operating in the COVID-19 saliva screening test potential market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Danaher Corporation, University of North Carolina at Chapel Hill, Hologic Inc., Beaumont Health, PerkinElmer Inc., Quidel Corporation, University of Illinois at Urbana-Champaign, Cepheid, Seegene Inc., ARUP Laboratories, Vatic Health Limited, Ambry Genetics Corporation, LumiraDx Ltd., Yale School of Public Health, Gravity Diagnostics, Psomagen Inc., Fluidigm Corporation, Phosphorus Diagnostics LLC, DxTerity Diagnostics Inc., University of Notre Dame, MOgene, FLuroTech Ltd.

North America was the largest region in the COVID-19 saliva screening test potential market in 2024. The regions covered in the COVID-19 saliva screening test potential market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the COVID-19 saliva screening test potential market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The COVID-19 saliva screening test potential market consist revenues earned by entities by providing services such as sample collection services, laboratory testing services, diagnostic reporting services, and screening and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 saliva screening test potential market also consists of sales of saliva collection kits, rapid saliva testing kits, laboratory testing supplies, and automated sample processing systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

COVID-19 Saliva Screening Test Potential Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 saliva screening test potential market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for covid-19 saliva screening test potential ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 saliva screening test potential market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Location: Travel Stations; Sports Arenas; Entertainment Venues; Corporate Campus Environments; Universities And Colleges; Factories; Other Locations
2) By Technology: Fluorescence-Labelled Antigen; RT-PCR; CRISPR-Cas9
3) By Mode Of Testing: Centralized Testing; Decentralized Testing
Subsegments:
1) By Travel Stations: Airports; Train Stations; Bus Stations; Seaports
2) By Sports Arenas: Stadiums; Arenas; Event Halls
3) By Entertainment Venues: Theaters; Concert Halls; Amusement Parks; Nightclubs
4) By Corporate Campus Environments: Offices; Corporate Campuses; Business Parks
5) By Universities And Colleges: Higher Education Campuses; Research Institutions; Student Housing Areas
6) By Factories: Manufacturing Plants; Production Facilities; Industrial Sites
7) By Other Locations: Healthcare Facilities; Government Buildings; Public Transportation Hubs; Shopping Centers; Other Public Or Private Venues
Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Danaher Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29903

1. Executive Summary

2. COVID-19 Saliva Screening Test Potential market Characteristics

3. COVID-19 Saliva Screening Test Potential market Trends And Strategies

4. COVID-19 Saliva Screening Test Potential market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global COVID-19 Saliva Screening Test Potential Growth Analysis And Strategic Analysis Framework

5.1. Global COVID-19 Saliva Screening Test Potential PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global COVID-19 Saliva Screening Test Potential market Growth Rate Analysis
5.4. Global COVID-19 Saliva Screening Test Potential Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global COVID-19 Saliva Screening Test Potential Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global COVID-19 Saliva Screening Test Potential Total Addressable Market (TAM)

6. COVID-19 Saliva Screening Test Potential market Segmentation

6.1. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Travel Stations
Sports Arenas
Entertainment Venues
Corporate Campus Environments
Universities And Colleges
Factories
Other Locations
6.2. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluorescence-Labelled Antigen
RT-PCR
CRISPR-Cas9
6.3. Global COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Centralized Testing
Decentralized Testing
6.4. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Travel Stations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Airports
Train Stations
Bus Stations
Seaports
6.5. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Sports Arenas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stadiums
Arenas
Event Halls
6.6. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Entertainment Venues, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Theaters
Concert Halls
Amusement Parks
Nightclubs
6.7. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Corporate Campus Environments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Offices
Corporate Campuses
Business Parks
6.8. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Universities And Colleges, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Higher Education Campuses
Research Institutions
Student Housing Areas
6.9. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Factories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Manufacturing Plants
Production Facilities
Industrial Sites
6.10. Global COVID-19 Saliva Screening Test Potential Market, Sub-Segmentation Of Other Locations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Healthcare Facilities
Government Buildings
Public Transportation Hubs
Shopping Centers
Other Public Or Private Venues

7. COVID-19 Saliva Screening Test Potential market Regional And Country Analysis

7.1. Global COVID-19 Saliva Screening Test Potential market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global COVID-19 Saliva Screening Test Potential market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific COVID-19 Saliva Screening Test Potential market

8.1. Asia-Pacific COVID-19 Saliva Screening Test Potential market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China COVID-19 Saliva Screening Test Potential market

9.1. China COVID-19 Saliva Screening Test Potential market Overview
9.2. China COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India COVID-19 Saliva Screening Test Potential market

10.1. India COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan COVID-19 Saliva Screening Test Potential market

11.1. Japan COVID-19 Saliva Screening Test Potential market Overview
11.2. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia COVID-19 Saliva Screening Test Potential market

12.1. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia COVID-19 Saliva Screening Test Potential market

13.1. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea COVID-19 Saliva Screening Test Potential market

14.1. South Korea COVID-19 Saliva Screening Test Potential market Overview
14.2. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe COVID-19 Saliva Screening Test Potential market

15.1. Western Europe COVID-19 Saliva Screening Test Potential market Overview
15.2. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK COVID-19 Saliva Screening Test Potential market

16.1. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany COVID-19 Saliva Screening Test Potential market

17.1. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France COVID-19 Saliva Screening Test Potential market

18.1. France COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy COVID-19 Saliva Screening Test Potential market

19.1. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain COVID-19 Saliva Screening Test Potential market

20.1. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe COVID-19 Saliva Screening Test Potential market

21.1. Eastern Europe COVID-19 Saliva Screening Test Potential market Overview
21.2. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia COVID-19 Saliva Screening Test Potential market

22.1. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America COVID-19 Saliva Screening Test Potential market

23.1. North America COVID-19 Saliva Screening Test Potential market Overview
23.2. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA COVID-19 Saliva Screening Test Potential market

24.1. USA COVID-19 Saliva Screening Test Potential market Overview
24.2. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada COVID-19 Saliva Screening Test Potential market

25.1. Canada COVID-19 Saliva Screening Test Potential market Overview
25.2. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America COVID-19 Saliva Screening Test Potential market

26.1. South America COVID-19 Saliva Screening Test Potential market Overview
26.2. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil COVID-19 Saliva Screening Test Potential market

27.1. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East COVID-19 Saliva Screening Test Potential market

28.1. Middle East COVID-19 Saliva Screening Test Potential market Overview
28.2. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa COVID-19 Saliva Screening Test Potential market

29.1. Africa COVID-19 Saliva Screening Test Potential market Overview
29.2. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Location, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa COVID-19 Saliva Screening Test Potential market, Segmentation By Mode Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. COVID-19 Saliva Screening Test Potential market Competitive Landscape And Company Profiles

30.1. COVID-19 Saliva Screening Test Potential market Competitive Landscape
30.2. COVID-19 Saliva Screening Test Potential market Company Profiles
- 30.2.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. COVID-19 Saliva Screening Test Potential market Other Major And Innovative Companies

31.1. University of North Carolina at Chapel Hill
31.2. Hologic Inc.
31.3. Beaumont Health
31.4. PerkinElmer Inc.
31.5. Quidel Corporation
31.6. University of Illinois at Urbana-Champaign
31.7. Cepheid
31.8. Seegene Inc.
31.9. ARUP Laboratories
31.10. Vatic Health Limited
31.11. Ambry Genetics Corporation
31.12. LumiraDx Ltd.
31.13. Yale School of Public Health
31.14. Gravity Diagnostics
31.15. Psomagen Inc.

32. Global COVID-19 Saliva Screening Test Potential market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The COVID-19 Saliva Screening Test Potential market

34. Recent Developments In The COVID-19 Saliva Screening Test Potential market

35. COVID-19 Saliva Screening Test Potential market High Potential Countries, Segments and Strategies

35.1 COVID-19 Saliva Screening Test Potential market In 2029 - Countries Offering Most New Opportunities
35.2 COVID-19 Saliva Screening Test Potential market In 2029 - Segments Offering Most New Opportunities
35.3 COVID-19 Saliva Screening Test Potential market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer